Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Sinergi Inti Andalan Prima Tbk. (INET) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Sinergi Inti Andalan Prima Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Sinergi Inti Andalan Prima Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp234 (market cap 316.25B, 20.9K 24h volume), while Sinergi Inti Andalan Prima Tbk. trades at Rp226 (market cap 5.06T, 170.83M 24h volume). The key difference: Sinergi Inti Andalan Prima Tbk. is far larger — about 16× Diagnos Laboratorium Utama Tbk.'s market cap, and Sinergi Inti Andalan Prima Tbk. is more actively traded (170.83M versus 20.9K). Which is the better fit depends on your goals.

DGNSINET
Market Cap
316.25B5.06T
Volume
20.9K170.83M
Lot
2091.71M
Turnover
4.83M39.11B
Average Price
231.06228.94
Value
4.83M39.11B
Indicative Equilibrium Price
230232
Indicative Equilibrium Volume
2.4K23.71K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
INET
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Sinergi Inti Andalan Prima Tbk.

PT Sinergi Inti Andalan Prima Tbk (the Company) was established on December 16, 2016 based on Notarial Deed No. 1 of Devi Prihartanti, S.H., notary in South Tangerang. The Company started its commercial operations in 2017.

Read more on INET